A first-in-human, pharmacokinetic and tolerability study of LFF 571 at single and multiple doses in volunteers.
Phase of Trial: Phase I
Latest Information Update: 10 Sep 2012
At a glance
- Drugs LFF 571 (Primary)
- Indications Clostridium infections
- Focus Adverse reactions; Pharmacokinetics
- 27 Sep 2011 New trial record
- 20 Sep 2011 Results presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy.